Agios Reports First Quarter 2015 Financial Results and Outlines Late-Stage Clinical Development for AG-221 and AG-120

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. COHR
10. AMC

Go back to Agios Reports First Quarter 2015 Financial Results and Outlines Late-Stage Clinical Development for AG-221 and AG-120
AGIOS PHARM (NASDAQ: AGIO) Delayed: 33.95 --0 (-0%)
Previous Close $33.95    52 Week High $71.49 
Open $33.95    52 Week Low $33.50 
Day High $33.95    P/E N/A 
Day Low $33.95    EPS $-1.18 
Volume 4